# Topical Ocular Mecamylamine in Diabetic Macular Edema (DME)

> **NCT00536692** · PHASE2 · COMPLETED · sponsor: **CoMentis**

## Conditions studied

- Diabetic Macular Edema

## Interventions

- **DRUG:** mecamylamine

## Key facts

- **NCT ID:** NCT00536692
- **Lead sponsor:** CoMentis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-09
- **Primary completion:** —
- **Final completion:** 2008-04
- **Target enrollment:** — (—)
- **Last updated:** 2008-04-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00536692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00536692, "Topical Ocular Mecamylamine in Diabetic Macular Edema (DME)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00536692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*